NOTIRETATUG REZETECAN
UNII H423BH2FBA

Substance Identification & Data

This profile provides standardized clinical and technical data for Notiretatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H423BH2FBA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3036556-53-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H423BH2FBA
CAS Registry Number
3036556-53-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NOTIRETATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C200198
National Cancer Institute reference terminology for clinical and research data.
INN ID
13714
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Notiretatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NOTIRETATUG REZETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN NECTIN-4) (HUMAN MONOCLONAL HRP04949 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HRP04949 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS NECTIN4 (NECTIN-4, NECTIN CELL ADHESION MOLECULE 4, PVRL4, POLIOVIRUS RECEPTOR-RELATED 4, PPR4, LNIR)), HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO REZETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN) (NOTIRETATUG REZETECAN)
NOTIRETATUG REZETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus